Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Sep 1997, 2275-2278, Vol 35, No. 9
AP Cullen, CD Long and AT Lorincz
A second-generation signal amplification, nucleic acid-based test for the
rapid detection and typing of herpes simplex virus (HSV) DNA was developed
and evaluated with artificial and clinical specimens. The analytical
sensitivity of the Hybrid Capture II (HC II) HSV DNA assay was determined
by testing either cloned HSV DNA or total genomic HSV DNA titrations and
resulted in detection thresholds of between 5 x 10(3) and 1 x 10(4) copies
per assay. Specificity was assessed by testing a panel of bacteria and
viruses commonly found in the female genital tract. Sensitivity was
assessed by testing 112 ulcerative genital lesions by the HC II assay and
comparing the results to those obtained by routine cell culture. Discrepant
results were resolved by PCR testing. After resolution of the discrepant
results, the sensitivity of the HC II assay compared to the consensus
result (the results of two of three tests, the HC II assay, culture, and
PCR, were in agreement) was 93.2% (41 of 44 specimens), and the specificity
was 100% (60 of 60 specimens). Culture gave a sensitivity of 84.1% (37 of
44 specimens) and a specificity of 100% (60 of 60 specimens) compared to
the consensus result. The results of HSV typing by the HC II assay and
culture agreed in all cases. The HC II assay is a rapid and accurate assay
for detecting and typing HSV types 1 and 2, with a sensitivity comparable
to that of culture and greater ease of use than culture.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Rapid detection and typing of herpes simplex virus DNA in clinical specimens by the hybrid capture II signal amplification probe test
Digene Corporation, Silver Spring, Maryland 20904, USA. Cullen@Digene.com
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|